Skip to main content

Table 2 Radiologic and pathologic response after docetaxel plus doxorubicin neoadjuvant chemotherapy

From: Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer

Response No. of Pts (%)
Radiologic response  
   Complete response 7 (4.8)
   Partial response 93 (64.1)
   Stable disease 42 (29.0)
   Progressive disease 3 (2.1)
Pathologic complete response  
   Yes 11 (7.6)
   No 134 (92.4)